Skip to content

HIV treatment may need to start above 300 CD4s in HIV/hepatitis C coinfected, study suggests

Siblings of HIV/HCV coinfected patients also have higher mortality risk

Weight-based ribavirin dosing achieves high success rates in hepatitis C/HIV co-infected patients

New risk factors for severe liver toxicity identified in largest ever clinical trial-based analysis

BHIVA: One-in-three UK HIV deaths 'not directly related to HIV'

HIV/HCV co-infection may lessen CD4 response to antiretroviral therapy

Lab markers can predict advanced liver fibrosis in more than 90% of cases in HIV/HCV coinfected

Higher baseline HCV viral load and CD4 percentage predict response to hepatitis C treatment in HIV/HCV co-infected patients

Treatment of acute hepatitis C produces good response rates in HIV-positive patients